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Using density gradient centrifugation and [3H]ry- 
anodine as a specific marker,  the  ryanodine  receptor- 
Ca2+  release  channel complex from Chaps-solubilized 
canine  cardiac  sarcoplasmic  reticulum  (SR)  has been 
purified  in  the  form of an -30 S complex,  comprised 
of M, - 400,000 polypeptides. Purification  resulted  in 
a specific activity of -450 pmol bound  ryanodinelmg 
of protein, a 60-70% recovery of ryanodine  binding 
activity,  and  retention of the  high  affinity  ryanodine 
binding  site (KO = 3 nM). Negative  stain  electron mi- 
croscopy revealed a 4-fold  symmmetric,  four-leaf clo- 
ver  structure,  which could fill a box -30 X 30 nm and 
was thus morphologically similar to the SR-trans- 
verse-tubule, junctionally associated foot structure. 
The  structural,  sedimentation,  and  ryanodine  binding 
data  strongly suggest there is one  high  affinity  ryano- 
dine  binding site130 S complex,  comprised of four M, - 400,000 subunits.  Upon  reconstitution  into  planar 
lipid  bilayers,  the  purified complex exhibited a Ca2+ 
conductance (70 pS  in 50 mM Ca2+) similar  to  that of 
the  native  cardiac  Ca2+  release  channel (75 pS). The 
reconstituted complex was  also  found  to conduct  Na+ 
(550 pS  in 500 mM Na+) and often  to  display complex 
Na+  subconducting  states.  The  purified  channel could 
be  activated by  micromolar  Ca2+ or millimolar  ATP, 
inhibited by  millimolar Mg2+ or micromolar  ruthenium 
red,  and modified to a long-lived  open  subconducting 
state by  ryanodine.  The  sedimentation,  subunit com- 
position,  morphological, and  ryanodine  binding  char- 
acteristics of the  purified  cardiac  ryanodine  receptor- 
Ca2+ release channel complex were similar to those 
previously  described  for  the  purified  ryanodine  recep- 
tor-Ca2+  release  channel  complex  from  fast-twitch 
skeletal muscle. 
Cardiac  muscle contraction is triggered by a rapid  increase 
in the cytoplasmic free Ca2+ concentration. This transient 
increase in Ca2+ occurs during  the  excitation-contraction cou- 
pling process, initiated  in  response  to a muscle cell surface 
membrane  action  potential, when extracellular calcium ions 
move into  the cell and  intracellular calcium ions  are released 
from a Ca2+  storing  membrane  system,  the sarcoplasmic re- 
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ticulum  (SR).’ Although the  detailed  mechanism of physio- 
logical SR Ca2+ release remains  to  be  determined  (for reviews 
see Refs. 1-3), recent  rapid mixing-vesicle  ion  flux and  planar 
lipid  bilayer-single channel measurements have suggested 
that  cardiac SR Ca2+ release is  mediated by a high conduct- 
ance Ca2+ channel  that  is  activated by micromolar Ca2+  and 
millimolar ATP  and  inhibited by  millimolar M e  (4, 5). The 
presence of a similarly ligand-gated  Ca2+  conducting  channel 
has been  previously  observed in “heavy,” junctionally derived 
SR vesicle fractions  from  skeletal muscle (6-14). 
The  Ca2+ release behavior of heavy cardiac  and  skeletal SR 
vesicles is significantly  affected by the  neutral  plant alkaloid, 
ryanodine, which binds specifically and  at  nanomolar  concen- 
trations  to  the  cardiac  and  skeletal  Ca2+ release channels (5, 
15-17). At nanomolar concentrations, ryanodine locks the 
channel  into a long-lived open  subconductance  state, while a t  
concentrations above 10 PM, ryanodine completely closes the 
channel (16-21).  Using [3H]ryan~dine  as   Ca2+  release chan- 
nel-specific  ligand, the detergent-solubilized ryanodine recep- 
tor from skeletal muscle has been isolated by sequential 
column chromatography  (22),  immunoaffinity  chromatogra- 
phy  (20),  and  density  gradient  centrifugation  (23),  as  poly- 
peptide  with  apparent relative  molecular mass (Mr) of 
-400,000. Electron microscopy  revealed  morphological simi- 
larity with the “feet” structures which span the transverse 
(T-)  tubule-SR  junctions (23, 24), and  reconstitution of the 
purified receptor  into  planar lipid bilayers resulted in con- 
ductance  and pharmacological  behavior characteristic of the 
native  CaZ+ release channel (23, 25, 26). 
The cardiac muscle [3H]ryanodine  receptor  has also been 
purified by sequential column chromatography (22) and by 
density gradient centrifugation (27). Lai et al. (27) showed 
that  the Chaps-solubilized cardiac  receptor, like the  skeletal 
receptor,  migrated  through sucrose gradients  as a large com- 
plex with  an  apparent  sedimentation coefficient of  -30 S and 
displayed a major  polypeptide band of M, - 400,000 on SDS- 
polyacrylamide gels. Incorporation of the purified receptor 
into  planar lipid  bilayers  induced  single Ca2+  channel  currents 
with conductance  and  gating  kinetics  similar  to  those of native 
cardiac Ca2+ release channels (27). These results suggested 
that  the purified cardiac  ryanodine  receptor complex contains 
the  Ca2+-conducting pore of the  cardiac  Ca2+ release channel, 
although  retention of the full range of regulatory sites of the 
native  channel was not  demonstrated. 
Reported here is the  further  characterization of the purified 
The abbreviations used are: SR, sarcoplasmic reticulum; EGTA, 
[ethylenebis(oxyethylenenitrilo)] tetraacetic acid; Pipes, 1,4-pipera- 
zinediethanesulfonic acid; Hepes, N-2-hydroxyethylenepiperazine- 
N’-2-ethanesulfonic acid; DIFP, diisopropylfluorophosphate; Chaps, 
3-[3-cholamidopropyl)dimethylammonio]-l-propanesu1fonate;pS, 
picoSiemens; SDS, sodium dodecyl sulfate. 
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cardiac ryanodine receptor-Ca2+ release channel complex. We 
find that the purified cardiac ryanodine receptor (i) has a 
morphology and  subunit composition similar to  that reported 
for the purified skeletal ryanodine receptor, (ii) retains its 
Ca", Mg2+, adenine nucleotide, ruthenium red, and ryanodine 
regulatory sites,  (iii) conducts sodium ions, and  (iv) displays 
sublevel conductances not observed in native channel record- 
ings. Some of this work has been previously presented in 
abstract form (28). 
EXPERIMENTAL PROCEDURES 
Materials-Ryanodine was obtained from AgriSystems Interna- 
tional  (Wind Gap, PA)  and [3H]ryanodine (54.7 Ci/mmol) from Du 
Pont-New England Nuclear. Phospholipids were purchased from 
Avanti Polar Lipids Inc. (Birmingham, AL) and Chaps from Boeh- 
ringer Mannheim. The SDS gel molecular weight standards were 
obtained from  Sigma. All other reagents are of reagent grade. 
Isolation of Membranes-Cardiac SR membranes were prepared 
from canine ventricular tissue similarly as previously described (5, 
21). After anesthetizing the dogs, hearts were removed via median 
sternotomy and placed immediately in ice-cold 0.3 M sucrose solution. 
The tissue was minced and homogenized in 7 volumes of 0.3 M sucrose, 
2 mM EGTA, 1 mM diisopropyl fluorophosphate (DIFP), 20 mM 
KHepes, pH 7.4, a t  4 "C for 60 s in  a Waring blender, followed by 
centrifugation for 20 min at 5000 rprn in a GSA rotor  in  a Sorvall 
RC-2 centrifuge. After filtering the  supernatant through two layers 
of cheesecloth and centrifuging for 60 min at  33,000 rprn in  a Beckman 
Type 35 rotor, the resulting pellets were resuspended in 0.3 M sucrose 
and 10 mM KPipes, pH 6.8, quick frozen, and stored at  -135 "C. 
Purification of Ryanodine Receptor Complex-Frozen SR mem- 
branes were rapidly thawed and incubated at 0.2 mg/ml in 0.5 M 
NaC1, 20 mM NaP207, 20 mM NaH2P04, 0.1 mM EGTA, 0.1 mM 
Ca2+, and 1 mM DIFP at pH 7. After 1 h on ice, the sample was 
underlayed in  a Beckman Ti45 rotor tube with 0.5 M sucrose and 20 
mM NaPipes, pH 7, and centrifuged for 30 min at  35,000 rpm. The 
supernatant,  containing  extracted protein including myosin,  was dis- 
carded and the pellet was resuspended in 1.0 M NaCI, 100 p~ EGTA, 
150 p~ Ca2+, 1 mM DIFP,  and 20 mM NaPipes, pH 7.2. Membranes 
were solubilized by the addition of 10% Chaps  containing  phospha- 
tidylcholine, phosphatidylethanolamine, and phosphatidyserine 
(7:2:1, PC/PE/PS),  to give final protein, phospholipid, and  detergent 
concentrations of 1.0-1.5 mg/ml, 5 mg/ml, and 1.5%, respectively. 
After addition of 200 nM [3H]ryanodine, the sample was incubated 
for 2.5 h at 22 "C and  then centrifuged at 30,000 rpm for 30  min in a 
Beckman Ti75 rotor. The  supernatant (15 ml),  containing the solu- 
bilized ryanodine receptor, was layered at  the top of six, 5-20% linear 
sucrose gradients, containing 1% Chaps, 1.0 M NaCl, 0.1 mM EGTA, 
0.15 mM Ca", 1 mM DIFP, 20 mM NaPipes, pH 7.2, and  5 mg/ml of 
PC/PE/PS.  The gradients were centrifuged at 2 "C in a Beckman 
SW28 rotor a t  26,000 rpm for 16 h, followed by fractionation  into 
-2.0-ml portions, 0.05 ml of which  were added to 4.0 ml of ScintiVerse 
E scintillation fluid (Fisher). After locating the bound [3H]ryanodine 
radioactivity, the ryanodine receptor peak fractions were quick-frozen 
and stored at -135 "C. Unlabeled solubilized SR membranes were 
centrifuged through parallel sucrose gradients to provide purified 
receptor for the bilayer reconstitution and [3H]ryanodine postlabeling 
studies. 
Measurement of PHIRyanodine Bir~ding-[~H]Ryanodine (54.7 Ci/ 
mmol) was added to  the sample at a  concentration of up to 8 nM. 
Greater concentrations were prepared as mixtures of labeled and 
unlabeled ryanodine. Bound and free [3H]ryanodine were separated 
by a filter assay (15) with the following modifications. Aliquots of  25 
~l of vesicle suspensions or solubilized samples were diluted 20-fold 
with ice-cold H20, placed on a Whatman GF/B glass-fiber filter 
presoaked in 5% polyethyleneimine, and rinsed three  times with 5 ml 
of ice-cold H20. Total radioactivity and radioactivity remaining with 
the filter were determined by liquid scintillation counting. Nonspe- 
cific binding, assumed to be linear with respect to ryanodine concen- 
tration, was determined with excess cold ryanodine (20-40 FM) and 
substracted from the  total bound [3H]ryanodine. 
Protein Assay-Protein concentrations were determined by the 
method of Kaplan and Pederson (29) using amido black with 0.45 p~ 
Millipore filters (Type HA). Bovine serum albumin was used as the 
protein standard. 
SDS-Polyacrylamide Gel Electrophoresis-Polyacrylamide gel elec- 
trophoresis was performed in 5-12% polyacrylamide gradient gels, in 
a Hoefer SE 600 Vertical Slab Gel Unit with the buffer system of 
Laemmli (30). Samples were denatured at 90 "C for 5 min in 2% SDS, 
2% P-mercaptoethanol, 0.1 M Tris-HC1, pH 6.8, and 10% glycerol 
before electrophoresis. Gels were stained with silver according to 
Oakley et al. (31). 
Electron Microscopy-The ryanodine receptor complex, isolated as 
described above but in the absence of exogenous phospholipid, was 
examined by electron microscopy using negative staining. One drop 
of sample in 1% Chaps, 1.0 M NaCl, -15% sucrose, and 20 mM 
NaPipes, pH 7.2, was applied to a  thinly carbon-coated grid previously 
glow discharged, and  then washed with 3 drops of 2% uranyl acetate, 
and air dried. 
Planar Bilayer Measurements-The solubilized ryanodine receptor 
complex, purified as described above but in the absence of [3H] 
ryanodine, was fused into a Mueller-Rudin planar lipid bilayer. The 
bilayer was formed from a mixture of phosphatidylethanolamine, 
phosphatidylserine, and phosphatidylcholine, in the ratio 5:3:2 (50 
mg/ml phospholipid in decane), across a 0.25-mm hole in  a symmetric 
100 mM NaCl buffer solution containing 6 or 100 g M  free Ca2+. 
Following formation and stabilization of the bilayer, an aliquot of 
sample (1-3 gl) was added to  the cis chamber. Current signals were 
stored on video cassette using a cut-off frequency of 4 kHz. Current 
signals were filtered at 300 Hz, sampled at 1 kHz, and analyzed as 
described previously by Smith et al. (6). Free Ca2+ concentrations 
were calculated using a computer program and  the binding constants 
published by Fabiato (32). 
RESULTS 
Purification and Ryanodine Binding Properties of the Ry- 
anodine Receptor  Complex-Ryanodine, a  neutral  plant  alka- 
loid, binds with nanomolar affinity to  the cardiac SR Ca2+ 
release channel  (Table I). In order to optimize the use of [3H] 
ryanodine as  a  channel marker during purification, the  sta- 
bility of ryanodine binding to solubilized SR membranes was 
examined. SR preparations (1.5 mg of protein/ml) were sol- 
ubilized with 1.5% of the zwitterionic detergent Chaps, in the 
presence of 5 mg/ml phospholipid, 50 p~ free ca2+, 1.0 M 
NaCl, 20 mM NaPipes, pH 7.2, and 200 nM [3H]ryanodine. 
After 2.5 h at 22 "C, [3H]ryanodine binding had reached 
equilibrium (not shown), and -90% of the [3H]ryanodine 
binding activity had been solubilized (Table 11). The solubi- 
lized, [3H]ryanodine-labeled SR membranes were diluted 16- 
fold in a 10% sucrose, 1.0 M NaC1, 20 mM NaPipes, pH 7.2 
buffer containing  either:  (i) 0.2 pM free ca2+, (ii) 50 p M  free 
Ca2+, (iii) 0.2 pM free Ca2+ plus 5.0 mg/ml  exogenous phos- 
pholipid, or (iv) 50 p~ free Ca2+ plus 5.0 mg/ml exogenous 
phospholipid. Bound [3H]ryanodine was then  determined 
after various incubation intervals from 1 to 70 h at  4 "C. As 
shown in Fig. 1, in the absence of Ca2+ and/or phospholipid, 
[3H]ryanodine binding decreased steadily with time. The com- 
bined presence of Ca2+ and phospholipid stabilized ryanodine 
binding, and  thus,  both were present  throughout the entire 
TABLE I 
Binding properties of the ryanodine receptor-Ca2+ 
release channel complex 
SR membranes were labeled with 0.5-40,000 nM [3H]ryanodine in 
1 M NaC1, 100 p M  EGTA, 150 PM Ca2+, 1 mM DIFP, and 20 mM 
NaPipes, pH 7.2, for 4 h at  37  "C. Chaps-solubilized SR membranes 
and purified ryanodine receptor in  5 mg/ml phospholipid were labeled 
as above at 22 "C for 4 and 4-20 h, respectively. The KD and B ,  
values, obtained by Scatchard analysis, are  the mean -+ S. D. from 
five determinations for fractions 14-16 and from three  determinations 
for SR membranes and solubilized SR membranes. 
~ 
Fraction KD B,, 
nM pmollmg 
2. CHAPS-solubilized 
1. SR membranes 7 f l  10 f 2 
6 + 2   S f 1  
3. Sucrose gradient 3 f 2  250 f 50 
SR membranes 
(fractions 14-16) 
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TABLE I1 
Purification of the  ryanodine  receptor-Ca2+ release channel complex 
The complex was purified from Chaps-solubilized SR membranes as described under "Experimental Procedures." 
The values are from a  typical  experiment in which material from six gradients was combined. 
[3H]Ryanodine binding 
Specific activity ~ o t a l  activity Purification 
Fraction Protein 
ery 
mg Pmollmg P W l  % 
1. SR membranes 18 13 234 100 1 
2. CHAPS-solubilized SR membranes 15.6 13.8 216 92 1 
3. Sucrose  gradient (fractions 14-16) 0.33 455 150 64 35 
0 25  50 75 100 
Time Chl 
FIG. 1. Effect of phospholipid and Caz+ on stability of ['HI 
ryanodine binding to solubilized SR membranes. SR mem- 
branes were solubilized and labeled as described under "Experimental 
Procedures." The solubilized protein (3 mg/ml) was then diluted  16- 
fold into 20 mM NaPipes, pH 7.2, 1 M NaCI, 1.0% Chaps, and 10% 
sucrose, containing EGTA, Ca2+ and/or exogenous phospholipid to 
give final concentrations of  0.2 p~ free Ca2+ (O), 50 p~ free Ca2+ (X), 
0.2 pM free Ca2+ + 5 mg/ml exogenous phospholipid (O), or 50 pM 
free Ca2+ + 5 mg/ml exogenous phospholipid (A). Bound  [3H]ryano- 
dine was determined by filtration of samples after various  incubation 
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FIG. 2. ['Hlryanodine (0) and protein (X) sedimentation 
profile of Chaps-solubilized SR membranes  centrifuged 
through a 5-20'70 linear sucrose  gradient. An apparent sedimen- 
tation coefficient for the ryanodine receptor-Caz' release channel 
complex of -30 S was obtained by extrapolation of an enzyme marker 
calibration  curve (Sm.w of 16, 11.2, and 7.6, Escherichia coli j3-galac- 
tosidase, bovine liver catalase, and yeast alcohol dehydrogenase, 
respectively) (not shown). 
purification procedure, unless otherwise indicated. 
The Chaps-solubilized ryanodine receptor was isolated by 
centrifugation through a linear sucrose gradient. A single 
small peak of radioactivity, comigrating with  a small protein 
peak, was located in the lower half of the gradient (Fig. 2). 
Radioactivity was decreased close to background levels in the 
lower  half of the gradient, when the solubilized membranes 
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FIG. 3. Silver-stained SDS-polyacrylamide gradient (5- 
12%) gel electrophoresis of cardiac SR membranes (M), 
Chaps-solubilized SR membranes ( S )  (3 pg each); gradient 
fractions 3, 5 ,  7, 9 (10 pl each); 11, pooled ryanodine  peak 
fractions (R; 14-16), and 19 (20 pl each). M, standards shown 
a t  the right are: carbonic anhydrase (29,000), ovalbumin (45,000), 
bovine serum  albumin (66,000), phosphorylase b (97,400), j3-galacto- 
sidase (116,000), myosin (205,000) and  c~~-macroglobulin (340,000). 
were incubated  with  a 100-fold excess (20 PM) of unlabeled 
ryanodine (not shown). The large amount of radioactivity at  
the  top of the gradient in both cases was found to be unbound 
[3H]ryanodine. Sedimentation of parallel  gradients  containing 
protein standards indicated the ryanodine receptor to have 
an  apparent sedimentation coefficient of -30 S, suggesting 
that  the receptor exists as a large macromolecular complex 
with a molecular weight in excess of M,  1,000,000. SDS- 
polyacrylamide gel electrophoresis of the sucrose gradient 
fractions indicated the specific comigration of a major M,  - 
400,000 polypeptide with the ryanodine peak, as this  band 
was absent in  all other fractions (Fig. 3). 
The above procedure typically resulted  in  a -35-fold en- 
richment and 60-70% recovery of ryanodine binding activity 
from SR membranes  (Table 11). A maximal specific activity 
of  -450 pmol of bound [3H]ryanodine/mg of purified, prela- 
beled receptor protein corresponded to  the presence of one 
ryanodine binding site per four to five M, - 400,000 polypep- 
tide subunits. The [3H]ryanodine binding properties of the 
receptor, purified in the absence of ryanodine, were deter- 
mined by Scatchard analysis (Fig. 4 and Table 11). The 
purified receptor exhibited a single high affinity ryanodine 
binding site with K D  = 3 f 2 nM , which was similar to  that 
measured for the SR membranes, KO = 7 f 1 nM, and for the 
Chaps-solubilized SR membranes, KO = 6 f 2 nM. The 
presence of a high affinity binding site with a 4-5-fold  higher 
dissociation constant ( K D  = 17 nM) in addition to a low 
affinity site with KD of 1060 nM has been reported by Inui et 
al. (22) for the purified cardiac ryanodine receptor. Scatchard 
1332 Cardiac Ca2+ Release Channel 
0 100 200 300 
Bound Cpmol /mg3 
FIG. 4. Scatchard analysis of [SH]ryanodine binding to the 
purified ryanodine receptor-Ca2+ release channel complex. 
[‘HIRyanodine binding to the purified complex (10 pg of protein/ml) 
was carried out as described in Table I. High affinity binding was 
obtained by taking the difference between the total and nonspecific 
binding. Nonspecific binding, assumed to be linear with ryanodine 
concentration, was determined with excess unlabeled ryanodine (40 
pM) and was equivalent to 21 pmol/mgof protein at 200 nM ryanodine. 
FIG. 5. Morphology of the purified ryanodine receptor-Ca2* 
release channel complex, as revealed by negative stain elec- 
tron microscopy. A, field view containing both well-preserved and 
distorted four-leaf clover quatrefoils. Bar, 100 nm. R, selected images 
exhibiting well-preserved (top row) and distorted (bottom row, left 
three panels) four-leaf clover morphology. The -30 X 7 nm rectan- 
gular images (bottom row, right two panels) may be interpreted as 
edge views of the complex. Bar, 30 nm. 
plots yielded a Bmax for the purified receptor of 250 & 50 
pmol/mg of protein, which  was about one-half of the specific 
activity observed  when membranes were labeled with 200 nM 
[3H]ryanodine during solubilization. These results indicate 
that the high affinity ryanodine binding was retained, al- 
though -45% of the ryanodine binding activity was lost during 
isolation of the unlabeled receptor. 
Negatiue Stain Electron Microscopy  of the Purified Receptor 
Complex-Using negative stain electron microscopy, the mor- 
phology  of the purified  30 S complex  was  examined. A field 
view (Fig. 5A) illustrates the presence of particles exhibiting 
both well-preserved and distorted structures. Fig. 5B (top row) 
shows  enlarged,  selected  images that more  clearly identify the 
ryanodine receptor complex to exist as a quatrefoil or four- 
leaf  clover structure, very similar to  that described  previously 
for the ryanodine receptor-Ca2+ release channel complex  iso- 
lated from skeletal muscle,  in this laboratory (23). Four pro- 
tein “loops,” related by 4-fold symmetry, appear to project 
from an electron-dense region of the complex,  which  in turn 
forms a  central -1-2-nm  hole. Each protein loop, surrounding 
a hole or depression of -3 nm, extends -10 nm from the 
electron-dense region, which is also -10 nm in diameter. 
Approximately one-half of the particles lacked a well-pre- 
served quatrefoil structure  and appeared as donut-shaped, or 
as partial quatrefoils in  which one or more  loops were either 
unraveled or missing  (Fig. 5B,  bottom  row,  left three panels). 
The abundant presence of these distorted quatrefoils may 
correlate with the requirement of the cardiac SR receptor on 
the presence of phospholipid  for stability of ryanodine bind- 
ing, since for technical reasons, samples used for electron 
microscopy  were isolated in the absence of stabilizing phos- 
pholipid. The small proportion of -7 X 30-nm rectangular 
images  (Fig. 5, bottom  row, right two panels) were consistently 
observed  in  various preparations and could  be interpreted as 
an edge view of the complex. A similar observation for the 
purified skeletal muscle ryanodine receptor-Ca2+ release chan- 
nel complex has been reported (33). 
Reconstitution of the Purified Ca2+ Release Chunnel Complex 
into Planar Lipid  Bilayers-Reconstitution consisted of in- 
corporation of the solubilized receptor, isolated in the absence 
of ryanodine, into planar lipid  bilayers. Previous reconstitu- 
tion of the purified ryanodine receptor complex into planar 
lipid bilayers induced a Ca2+ current with a slope conductance, 
72 pS (27), very similar to  that observed  for the native cardiac 
SR Ca2+ release channel, 75 pS, recorded under identical 
conditions (4). In addition, the close similarity of the open 
and closed time constants measured for the native release 
channel and purified ryanodine receptor channels suggested 
the two were  very similar. 
We describe now the pharmacological  behavior of the pu- 
rified channel. When added to  the cis chamber, native and 
purified channels were found to fuse with the bilayer such 
that  the regulatory sites, corresponding to  the cytoplasmic 
side of the channel, were  generally present in the cis chamber. 
In all of our reconstitution experiments the purified complex 
was initially incorporated into bilayers in the presence of 
symmetric NaCl  buffer, as we found that  this buffer  system 
favored protein fusion  with the bilayer as well as optimized 
visualization of channel activity. As demonstrated in Fig. 6, 
large single-channel current fluctuations were obtained under 
these conditions. Similar to previously reported for the native 
cardiac Ca2+ release channel (4,5),  the reconstituted channel 
activity was markedly dependent on cis free Ca2+ concentra- 
tion. The fraction of channel open time (Po) in the presence 
of 100 p~ free Ca2+ cis ( P o  = 0.90)  was  lowered  upon reduction 
of cis free Ca”,  by addition of EGTA, to 28 p~ (PO = 0.85), 
0.4 p~ (PO = 0.30), and 0.04 p~ (Po = 0.05). The main 
conducting ion was Na+ and  not C1-, since channel conduct- 
ance was not significantly changed  when  NaCl  was  replaced 
in the cis and  trans chambers by 0.25 M NaPipes, whereas 
perfusion with choline chloride reduced currents to back- 
ground  levels (not shown). 
Fig. 7 shows that  the reconstituted 30 S complex conducts 
calcium  ions. The purified  complex was initially reconstituted 
into the bilayer in symmetric 0.5 M NaCl, 6 pM free Ca2+ 
buffer. The resulting single-channel Na+ current fluctuations 
are shown in Fig. 7A at a holding potential of +20 mV. From 
the current-voltage relationship under these conditions, a 
reversal potential close to zero and  a slope conductance of 
550 pS were obtained (Fig. 7C). Upon trans chamber perfusion 
with a 50 mM Ca(OH)2,250 mM Hepes  buffer, and cis perfu- 
sion with a 125 mM Tris, 250 mM Hepes, 10 pM free Ca2+ 
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buffer, a single channel activity was evident (Fig. 7B) ,  which 
displayed a  shift in the reversal potential to +30 mV, corre- 
sponding to a Ca2+ current with a slope conductance of 70 pS 
(Fig. 7C). Under the same recording conditions, similar values 
for Ca2+ conductance have been previously reported for the 
native channel (4). The activity of the Ca2+-conducting chan- 
nel was also dependent on cis free Ca2+ concentration. Upon 
reduction of cis free Ca2+ from 10 PM to 0.1 and 0.02 pM, the 
Po decreased from 0.58 initially to 0.20 and 0.05, respectively 
(Fig. 7B). 
Ryanodine modifies the conductance and gating behavior 
of the native cardiac Ca2+ release channel by inducing the 
formation of a long-lasting subconductance state (19). Fig. 8 
shows the behavior of a single Na+-conducting channel before 
and after the addition of 10 PM ryanodine cis. A relatively 
high concentration was used to reduce the delay otherwise 
FIG. 6. The purified ryanodine receptor-Ca'+ release chan- 
nel complex induces a Ca2+-activated Na+-current. Channel 
openings are denoted by upward deflections. Single channel Na+ 
pH 7, in the presence of 100 pM free Ca2+ cis (100 p M  EGTA, 200 p M  
currents were recorded in symmetric 100 mM NaC1, 20 mM NaPipes, 
CaCI2) (upper  trace). The free Ca2+ cis  was subsequently reduced, by 
the addition of EGTA, to 28,0.4, and 0.04 p~ (lower  traces). Holding 
potential, -25 mV; 0, open; and C, closed. 
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FIG. 7. The purified ryanodine receptor-Ca2+ release chan- 
nel complex induces a Ca2+-activated Ca2+ current. Channel 
openings are denoted by upward deflections. A, Single channel  Na+ 
currents were recorded in symmetric 500 mM NaCI, 20 mM NaPipes, 
pH 7, 6 p~ free Ca2+ buffer. Holding potential, +20 mV. B, after 
trans chamber perfusion with 50 mM Ca(OH)2, 250 mM Hepes Tris 
buffer, pH 7.4, and cis perfusion with 125 mM Tris, 250 mM Hepes, 
10 p M  free Ca2+ buffer, a single channel Ca2+ current was recorded 
(upper trace). The free Ca2+ cis was subsequently reduced by the 
addition of EGTA to 0.1 and 0.02 p~ (lower  truces). Holding potential, 
-40 mV. C, current-voltage relationship for the Na+ (solid l ine)  and 
Ca2+ (doshed line) conducting channel. -yNs = 550 pS, yc. = 70 pS. 
+ 10 pM RYANOOINE 2 mln 
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FIG. 8. Effect of ryanodine on single channel activity of the 
purified ryanodine receptor-Ca2+ release channel complex. 
Channel activity was recorded in symmetric 500 mM NaC1, 20 mM 
NaPipes, pH 7, 6 p~ free Ca2+ buffer, in the absence of ryanodine 
(upper  trace), and 2 min after addition of 10 p~ ryanodine cis (lower 
truces). Holding potential, -13 mV. 
FIG. 9. Ca2+, ATP, M g + ,  and ruthenium red sensitivity  of 
the Na+-conducting purified ryanodine receptor-Ca2+ release 
channel complex. Single channel  Na+  current, denoted as upward 
deflections, were recorded in symmetric 100 mM NaCl, 20 mM Na- 
Pipes, pH 7, in the presence of the indicated effectors, where ATP, Me, and ruthenium red were added to  the cis chamber. 
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TABLE 111 
Properties of purified  ryanodine  receptor-Ca2+ release channel complexes 
from cardiac and skeletal sarcoplasmic reticulum 
Cardiac Skeletal" 
Apparent  Sedimentation coefficient 30 S 30 S 
Negative stain images  Quatrefoil Quatrefoil 
Apparent  subunit composition Four polypeptides of M, - 400,000 Four polypeptides of M ,  - 400,000 
Kd of ryanodine  binding 3 nM 4 nM 
Number of high affinity  ryanodine  binding  sites/30 S complex One  One 
Main  conductance 
In 50 mM Caz+ 70 pS 100 p s  
In 500 mM Na+ 550 pS 600 pS 
Activation  by p M  Ca2+  and mM ATP Yes Yes 
Inhibition by mM M P  and p~ ruthenium red Yes Yes 
Modification by ryanodine Yes Yes 
Regulation 
"From  Lai et  al. (23). 
observed when nanomolar ryanodine is applied (21). Within 
2 min after the addition of ryanodine cis, both the gating 
kinetics and the conductance were abruptly modified, as the 
channel shifted into two long open states (Po - 1.0) with 
reduced unitary conductances of  280 and 360 pS correspond- 
ing to 50 and 60% of the initial 550 pS conductance. A complex 
subconductance behavior of the Na+-conducting channel 
could be also observed in the absence of ryanodine. In the 
upper truce (truce A )  of Fig. 9, a single current level was 
observed in the presence of cis and trans 100 p~ free Ca2+. 
The slope conductance was 180 pS in symmetric 100 mM 
NaC1, suggesting that a  channel of reduced conductance had 
been incorporated into the bilayer. Decrease of free Ca2+ cis 
(truce B )  and  trans (truce C) from 100 to 0.5 p~ induced the 
appearance of additional lower-conducting current levels 
without appreciably affecting the fraction of channel closed 
time. Traces D-F show that channel activity was dependent 
on ATP, M$+, and  ruthenium red, respectively. As previously 
shown in vesicle flux measurements and single channel re- 
cordings of the native channel  (4,  5), ATP activated, whereas 
M C  and  ruthenium red inactivated the channel. The  data of 
Fig. 9 suggest that  the Na+-conducting Ca2+ release channel 
may exist in several subconductance states,  as  has been pre- 
viously reported for the skeletal Ca2+ release channel (23, 25). 
However, the limited number of single channel recordings 
obtained are insufficient to rule out the possibility that  the 
recording in Fig. 9 represents  separate  channels of differing 
conductances and sensitivity to Ca", ATP,  and M P .  
DISCUSSION 
The ryanodine receptor from Chaps-solubilized canine  car- 
diac SR  has been purified by density gradient centrifugation 
as an -30 S complex comprised of M, - 400,000 polypeptides. 
As revealed by negative-stain electron microscopy (Fig. 51, 
the complex is morphologically similar to  the feet structures 
which span the T-tubule-SR  junctional gap in skeletal (34, 
35) and cardiac muscle (36). When incorporated into  planar 
lipid bilayers, the purified complex  was found to induce Na+ 
and Ca2+ currents with a conductance and pharmacology 
characteristic of the native cardiac SR Ca2+ release channel. 
We conclude that  the purified 30 S ryanodine receptor com- 
plex functionally encompasses the  SR Ca2+ release channel 
and is identical to the feet structures believed to mediate 
excitation-contraction coupling. 
Table I11 compares the properties of the ryanodine receptor- 
Ca2+ release channel complex  from cardiac and skeletal sar- 
coplasmic reticulum as purified by sucrose density gradient 
centrifugation in the presence of Chaps. Both receptors were 
isolated as -30 S oligomers comprised of M, - 400,000  poly- 
peptides, with retention of high affinity ryanodine binding, 
and exhibited a 4-fold symmetry with a quatrefoil, four-leaf 
clover appearance upon negative stain electron microscopy. 
In single channel recordings, the purified complexes in planar 
lipid bilayers conducted Ca2+ with unitary conductances sim- 
ilar to  the native channels. In addition,  both  channels were 
found to conduct Na+  and were regulated by Ca2+, ATP, M P ,  
and  ruthenium red and modified  by ryanodine. 
There were,  however, several subtle differences between the 
two receptors. First, the stability of [3H]ryan~dine binding to 
the solubilized cardiac receptor was found to be dependent on 
phospholipid andpM Ca2+. By contrast, the prelabeled skeletal 
receptor could  be isolated in the absence of lipid and Ca2+, 
without noticeable loss of [3H]ryanodine binding.' Phospho- 
lipid dependence of ryanodine binding may  be related to  the 
relatively reduced number of well-preserved quatrefoils in 
negatively stained specimens since around half of the cardiac 
complexes displayed a  distorted appearance. This  instability 
of the complex in  the absence of lipid may  be the origin of 
the slightly larger dimensions observed for the cardiac recep- 
tor, even though the cardiac subunits appeared to be of a 
slightly smaller molecular mass, as indicated by their greater 
mobility on SDS gels (27). Second, when purified by gradient 
centrifugation, [3H]ryanodine binding to  the cardiac receptor 
was less well preserved, with maximal binding of  -250 pmol/ 
mg  of protein  as compared to 540 pmol/mg of protein for the 
skeletal receptor (23). Third, differences established in vesi- 
cles flux and single channel recordings for the regulation and 
Caz+ conductance of the native cardiac and skeletal Ca2+ 
release channels (4-7)  were maintained in the purified com- 
plexes. The activity of the purified cardiac Ca2+ release chan- 
nel was found to be highly dependent on Ca2+ and was found 
to be less sensitive to ruthenium red inhibition than observed 
for the purified skeletal Ca2+ release channel (23). 
In  a previous report (22) the molecular mass of the cardiac 
and skeletal ryanodine receptors was estimated to be 4.4 X 
lo6 daltons from the dimensions of the receptors in electron 
micrographs (210 X 210 x 120 A), which  led to  the proposal 
that each foot consists of an oligomer of 12 monomers. This 
estimate was based on the assumption that  the entire foot 
structure volume  was  occupied with densely packed protein 
(1.37 g/cm3). The ultrastructural details of our negatively 
stained images clearly demonstrate that much of the foot 
structure is not occupied with densely packed protein. It 
appears that large spaces within and surrounding each protein 
loop are either devoid of, or contain only very low density 
protein, suggesting that  the value of  4.4 x lo6 dalton may  be 
K. Anderson, F. A. Lai, Q.-Y. Liu, E. Rousseau, H. P. Erickson, 
and G. Meissner,  unpublished studies. 
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an overestimation. We propose that,  as for the purified ry- 
anodine receptor complex from skeletal muscle (23), the car- 
diac complex  is an oligomer comprised of four M, - 400,000 
subunits. A molecular mass of -1,600,000 for the receptor 
complex agrees well with the  apparent sedimentation coeffi- 
cient of -30 S and is equivalent, as previously discussed (23), 
to having -35% of the volume of the complex comprised of 
protein. A specific [3H]ryanodine binding activity of 450 
pmol/mg of protein for the prelabeled purified cardiac recep- 
tor corresponds to one high affinity binding site per four to 
five M ,  - 400,000 subunits. The binding stoichiometry of the 
purified skeletal receptor was also determined to be one high 
affinity binding site per four M ,  - 400,000 subunits (23). This, 
taken together with the sedimentation and  structural  data, 
strongly suggests that  there is one high affinity [3H]ryanodine 
binding site per 30 S complex comprised of four M, - 400,000 
subunits. 
Recently, two other laboratories have also reported the 
reconstitution of the cardiac ryanodine receptor into  planar 
lipid bilayers (37, 38). As observed in the present study, 
Rardon et al. (37) described the reconstitution of a large 
conductance Ca2+ channel (80 pS), which was sensitive to 
regulation by Ca2+,  ATP,  and ryanodine. However, their  and 
our results show marked discrepancies with the study by 
Hymel et al. (38), which concluded that  the ryanodine receptor 
comprised Ca2+ channels with conductances ranging from 4 
to - 60 pS  and more. These values were determined in media 
containing  both K+ and Ca2+ which, in the light of our present 
results, suggests the possibility of a mixed monovalent and 
divalent conductance in their experiments. Further,  the pres- 
ence of 10 FM ryanodine was required to observe the “single” 
channel conductances of 4-60 pS. In addition, a puzzling 
observation was that single channel conductance increased 
with time, which  was considered to indicate the slow associ- 
ation of  12-16 copies of the Mr - 400,000 polypeptide into  a 
60 pS  channel.  Measurements of macroscopic currents  indi- 
cated activation by 10 nM ca’+, millimolar ATP, or micro- 
molar ryanodine, and  inhibition by M$+ and  ruthenium red. 
A novel observation made feasible in  the present study was 
the Na’ permeability of the cardiac Ca2+ release channel. The 
Na+ conductance properties of the native  channel  are difficult 
to define due to  the presence of a K+- and Na+-conducting 
channel  in the SR membrane (3). The large Na+ conductance 
of 550 pS reported here is similar to that of the - 600 pS 
conductance previously described for the skeletal channel 
(23). A further similarity was the presence of sublevels of 
conductance (23), although additional work will be required 
to more fully characterize this phenomenon for the cardiac 
channel. 
In conclusion, we have shown that  the purified ryanodine 
receptor from canine cardiac SR is equivalent to the foot 
structure and the SR Ca2+ release channel. The purified 
cardiac receptor shares many common characteristics with 
the ryanodine receptor recently isolated from skeletal muscle. 
The differences in size, stability,  and  function may  be related 
to  the different excitation-contraction coupling mechanisms 
thought to predominate within these tissues (1-3, 39). 
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